Shenzhen Hepalink Pharma News and Activities

Shenzhen Hepalink Pharma is a company listed under the stock ticker 002399 (CN).

Shenzhen Hepalink Pharma has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 23 main executives

Most searched biographies at Shenzhen Hepalink Pharma

• Yu Shan, Executive Director, General Manager and Group Vice Presid...
• Li Li, Chairman of the Board
• Xi Gao, Senior Vice President of Global Supply Chain

Create your alert
to follow the executive moves at Shenzhen Hepalink Pharma.

Shenzhen Hepalink Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Shenzhen Hepalink Pharma

Social media about Shenzhen Hepalink Pharma

• Shenzhen Hepalink Pharma on Wikipedia, Google News & Yahoo Finance
• Shenzhen Hepalink Pharma on LinkedIn, X (Twitter) & YouTube